Prevalence of NRT use and associated nicotine intake in smokers, recent ex-smokers and longer-term ex- Smokers

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Shahab, Lion ^a   Beard, Emma ^a   Brown, Jamie ^a   West, Robert ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COTININE; NICOTINE; NICOTINE GUM;

ADULT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NICOTINE REPLACEMENT THERAPY; PREVALENCE; SALIVA; SMOKING; SMOKING CESSATION; TOBACCO DEPENDENCE; UNITED KINGDOM; ENGLAND; EPIDEMIOLOGY; PREVENTION AND CONTROL; PROCEDURES; SOCIOECONOMICS; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; UTILIZATION;

DEMOGRAPHY; ENGLAND; HUMANS; LINEAR MODELS; NICOTINE; PREVALENCE; SMOKING; SMOKING CESSATION; SOCIOECONOMIC FACTORS; TOBACCO USE CESSATION PRODUCTS;

EID: 84911885204     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113045     Document Type: Article

References (34)

1. Beard E, McNeill A, Aveyard P, Fidler J, Michie S, et al. (2011) Association between use of nicotine replacement therapy for harm reduction and smoking cessation: a prospective study of English smokers. Tob Control 22: 118-122. tobaccocontrol-2011-050007 [pii];10.1136/tobaccocontrol-2011-050007 [doi].
2. Le Houezec J, McNeill A, Britton J (2011) Tobacco, nicotine and harm reduction. Drug Alcohol Rev 30: 119-123. 10.1111/j.1465-3362.2010.00264.x [doi].
3. Stratton S, Shetty P, Wallace R, Bondurant S (2001) Clearing the smoke: addressing the science base for tobacco harm reduction. Washington, DC: National Academy Press.
4. Fagerstrom KO, Hughes JR (2002) Nicotine concentrations with concurrent use of cigarettes and nicotine replacement: a review. Nicotine Tob Res 4 Suppl 2: S73-S79. 10.1080/1462220021000032753 [doi].
5. Wang D, Connock M, Barton P, Fry-Smith A, Aveyard P, et al. (2008) 'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis. Health Technol Assess 12: iii-xi.
6. Beard E, Fidler J, West R (2011) Is use of nicotine replacement therapy while continuing to smoke associated with increased nicotine intake? Evidence from a population sample. Psychopharmacology (Berl) 218: 609-610. 10.1007/s00213- 011-2359-4 [doi].
7. Tonnesen P, Paoletti P, Gustavsson G, Russell MA, Saracci R, et al. (1999) Higher dosage nicotine patches increase one-year smoking cessation rates: results from the European CEASE trial. Collaborative European Anti-Smoking Evaluation. European Respiratory Society. Eur Respir J 13: 238-246.
8. Wennike P, Danielsson T, Landfeldt B, Westin A, Tonnesen P (2003) Smoking reduction promotes smoking cessation: results from a double blind, randomized, placebo-controlled trial of nicotine gum with 2-year follow-up. Addiction 98: 1395-1402.
9. Schnoll RA, Patterson F, Wileyto EP, Heitjan DF, Shields AE, et al. (2010) Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial. Ann Intern Med 152: 144-151. 152/3/144 [pii]; 10.7326/0003-4819-152- 3-201002020-00005 [doi].
10. Joseph AM, Fu SS, Lindgren B, Rothman AJ, Kodl M, et al. (2011) Chronic disease management for tobacco dependence: a randomized, controlled trial. Arch Intern Med 171: 1894-1900. 171/21/1894 [pii]; 10.1001/archinternmed. 2011.500 [doi].
11. MHRA (2009) MHRA Public Assessment Report: The use of nicotine replacement therapy to reduce harm in smokers. London: Medicine and Healthcare Products Regulatory Agency (MHRA).
12. Fucito LM, Bars MP, Forray A, Rojewski AM, Shiffman S, et al. (2014) Addressing the evidence for FDA nicotine replacement therapy label changes: a policy statement of the Association for the Treatment of Tobacco use and Dependence and the Society for Research on Nicotine and Tobacco. Nicotine Tob Res 16: 909-914. ntu087 [pii];10.1093/ntr/ntu087 [doi].
13. Le Strat Y, Rehm J, Le FB (2011) How generalisable to community samples are clinical trial results for treatment of nicotine dependence: a comparison of common eligibility criteria with respondents of a large representative general population survey. Tob Control 20: 338-343. tc.2010.038703 [pii];10.1136/ tc.2010.038703 [doi].
14. Shiffman S, Sweeney CT (2008) Ten years after the Rx-to-OTC switch of nicotine replacement therapy: what have we learned about the benefits and risks of non-prescription availability? Health Policy 86: 17-26. S0168-8510(07)00197- 2 [pii];10.1016/j.healthpol.2007.08.006 [doi].
15. Shahab L, Brose LS, West R (2013) Novel Delivery Systems for Nicotine Replacement Therapy as an Aid to Smoking Cessation and for Harm Reduction: Rationale, and Evidence for Advantages over Existing Systems. CNS Drugs 27: 1007-1019. 10.1007/s40263-013-0116-4 [doi].
16. NICE (2013) Tobacco - Harm reduction. Available: http://publications.nice. org.uk/tobacco-harm-reduction-approaches-to-smoking-ph45.
17. Benowitz NL, Gourlay SG (1997) Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. J Am Coll Cardiol 29: 1422-1431. S073510979700079X [pii].
18. Benowitz NL, Jacob P III, Jones RT, Rosenberg J (1982) Interindividual variability in the metabolism and cardiovascular effects of nicotine in man. J Pharmacol Exp Ther 221: 368-372.
19. Black A, Beard E, Brown J, Fidler J, West R (2012) Beliefs about the harms of long-term use of nicotine replacement therapy: perceptions of smokers in England. Addiction 107: 2037-2042. 10.1111/j.1360-0443.2012.03955.x [doi].
20. Etter JF (2009) Dependence on the nicotine gum in former smokers. Addict Behav 34: 246-251. S0306-4603(08)00300-6 [pii]; 10.1016/j.addbeh. 2008.10.018 [doi].
21. Fidler JA, Shahab L, West O, Jarvis MJ, McEwen A, et al. (2011) 'The Smoking Toolkit Study': A national study of smoking and smoking cessation in England. BMC Public Health 11: 479.
22. Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J (1989) Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict 84: 791-799.
23. Fidler JA, Shahab L, West R (2011) Strength of urges to smoke as a measure of severity of cigarette dependence: comparison with the Fagerstrom Test for Nicotine Dependence and its components. Addiction 106: 631-638.
24. Kotz D, Brown J, West R (2013) Predictive validity of the Motivation To Stop Scale (MTSS): A single-item measure of motivation to stop smoking. Drug Alcohol Depend 128: 15-19. S0376-8716(12)00286-4 [pii]; 10.1016/j.drugalcdep. 2012.07.012 [doi].
25. Foulds J, Bryant A, Stapleton J, Jarvis MJ, Russell MAH (1994) The Stability of Cotinine in Unfrozen Saliva Mailed to the Laboratory. American Journal of Public Health 84: 1182-1183.
26. Feyerabend C, Russell MA (1990) A rapid gas-liquid chromatographic method for the determination of cotinine and nicotine in biological fluids. J Pharm Pharmacol 42: 450-452.
27. Hajek P, McRobbie H, Gillison F (2007) Dependence potential of nicotine replacement treatments: effects of product type, patient characteristics, and cost to user. Prev Med 44: 230-234.
28. West R, DiMarino ME, Gitchell J, McNeill A (2005) Impact of UK policy initiatives on use of medicines to aid smoking cessation. Tob Control 14: 166-171.
29. Silla K, Beard E, Shahab L (2014) Characterization of long-term users of nicotine replacement therapy: evidence from a national survey. Nicotine Tob Res 16: 1050-1055. ntu019 [pii]; 10.1093/ntr/ntu019 [doi].
30. Shahab L, Cummings KM, Hammond D, Borland R, West R, et al. (2009) The impact of changing nicotine replacement therapy licensing laws in the United Kingdom: findings from the International Tobacco Control Four Country Survey. Addiction 104: 1420-1427.
31. Hubbard R, Lewis S, Smith C, Godfrey C, Smeeth L, et al. (2005) Use of nicotine replacement therapy and the risk of acute myocardial infarction, stroke, and death. Tob Control 14: 416-421. 14/6/416 [pii]; 10.1136/tc.2005.011387 [doi].
32. Eliasson B, Taskinen MR, Smith U (1996) Long-term use of nicotine gum is associated with hyperinsulinemia and insulin resistance. Circulation 94: 878-881.
33. Sims TH, Fiore MC (2002) Pharmacotherapy for treating tobacco dependence: what is the ideal duration of therapy? CNS Drugs 16: 653-662. 161001 [pii].
34. Fidler JA, Stapleton JA, West R (2011) Variation in saliva cotinine as a function of self-reported attempts to reduce cigarette consumption. Psychopharmacology (Berl) 217: 587-593. 10.1007/s00213-011-2317-1 [doi].